Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07510945Phase 3Not yet recruiting
A Phase 3 trial of cipepofol in general anesthesia, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Planned start May 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07510945.